2021 年 04 月 1 绍兴贝斯美化工股份有限公司 2021 年第一季度报告全文 绍兴贝斯美化工股份有限公司 2021 年第一季度报告全文 绍兴贝斯美化工股份有限公司 2021 年第一季度报告 2021-028 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人陈峰、主管会计工作负责人屠汶君及会计机构负责人(会计主管 人员)屠汶君声明：保证季度报告中财务报表的真实、准确、完整。 2 绍兴贝斯美化工股份有限公司 2021 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | 营业收入（元） | 148,638,759.35 | 68,161,117.78 | 118.07% | | 归属于上市公司股东的净利润（元） | 24,294,564. ...

Financial Performance - Operating revenue for the reporting period was ¥71,169,813.84, a decrease of 16.66% year-on-year[8] - Net profit attributable to shareholders was ¥2,608,110.06, down 79.02% compared to the same period last year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥445,229.03, a decline of 96.13% year-on-year[8] - Basic earnings per share decreased to ¥0.02, down 85.71% from the previous year[8] - The weighted average return on equity was 0.26%, a decrease of 1.85% compared to the previous year[8] - Net profit dropped by 72.90% to ¥14,606,294.77, attributed to decreased sales due to the pandemic[18] - Total operating revenue for Q3 2020 was CNY 71,169,813.84, a decrease of 16.67% compared to CNY 85,392,809.64 in the same period last year[36] - Net profit for Q3 2020 was CNY 2,552,310.30, a decline of 80.00% from CNY 12,730,301.60 in Q3 2019[38] - The company reported a total profit of CNY 2,856,287.68 for Q3 2020, down 81.61% from CNY 15,479,072.60 in Q3 2019[38] - The company reported a net profit attributable to shareholders of the parent company of ¥14,988,577.04, down 70.9% from ¥51,549,361.04 in the previous year[47] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,244,947,981.61, an increase of 3.85% compared to the previous year[8] - Cash and cash equivalents decreased by 30.49% to ¥337,311,198.28 due to the purchase of financial products[17] - Accounts receivable decreased by 51.03% to ¥55,100,906.07 primarily due to a reduction in sales[17] - The company's current assets decreased to CNY 782,919,159.17 from CNY 796,245,029.33 at the end of 2019, reflecting a decline of approximately 1.8%[28] - The company's short-term borrowings increased to CNY 101,072,770.30 from CNY 42,046,840.20, representing a rise of approximately 140.5%[30] - Total liabilities rose to CNY 230,663,645.04 from CNY 189,421,031.60, marking an increase of about 21.8%[30] - The total liabilities increased to CNY 137,465,002.05 from CNY 81,037,492.84 year-on-year, reflecting a significant rise in financial obligations[34] Cash Flow - The net cash flow from operating activities was -¥8,959,785.91, a decrease of 23.23% year-on-year[8] - Cash flow from operating activities fell by 72.82% to ¥9,163,471.40, reflecting a decrease in cash received from sales[18] - Cash inflow from operating activities was CNY 324,299,385.05, down from CNY 424,115,615.17 in the previous year, indicating a decrease of about 23.5%[53] - The net cash flow from operating activities was CNY 9,163,471.40, significantly lower than CNY 33,717,236.80 in the same period last year, reflecting a decline of approximately 72.8%[55] - Cash inflow from financing activities was CNY 74,089,290.30, up from CNY 61,060,000.00 in the previous year, representing an increase of approximately 21.5%[56] - The net cash flow from financing activities was CNY 56,807,500.50, compared to CNY 52,847,225.08 in the same period last year, showing an increase of about 7.4%[56] Shareholder Information - The total number of shareholders at the end of the reporting period was 10,361[12] - The largest shareholder, Ningbo Beisi Beauty Investment Holdings Co., Ltd., holds 27.23% of the shares, with 18,150,000 shares pledged[12] Government Subsidies and Expenses - The company reported a total of ¥8,541,391.12 in government subsidies recognized in the current period[9] - Financial expenses rose significantly by 2990.37% to ¥3,855,150.33, driven by increased interest from new loans[17] - Research and development expenses for Q3 2020 were CNY 5,656,389.79, slightly down from CNY 5,777,666.58 in Q3 2019[37] - The company incurred financial expenses of ¥3,855,150.33, a substantial increase from ¥124,747.05 in the previous year[46] Future Outlook - The company plans to focus on market expansion and new product development in the upcoming quarters[46]

Financial Performance - The company's operating revenue for the reporting period was ¥180,020,984.28, a decrease of 37.71% compared to ¥289,017,700.55 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was ¥12,380,466.98, down 68.35% from ¥39,115,809.92 in the previous year[21]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥13,211,169.87, a decrease of 65.54% compared to ¥38,334,770.19 in the same period last year[21]. - The net cash flow from operating activities was ¥18,123,257.31, down 60.07% from ¥45,388,592.23 in the previous year[21]. - Basic earnings per share were ¥0.10, a decline of 76.74% from ¥0.43 in the same period last year[21]. - The diluted earnings per share were also ¥0.10, reflecting a 76.74% decrease compared to ¥0.43 in the previous year[21]. - The weighted average return on net assets was 1.23%, down 5.74% from 6.97% in the previous year[21]. - The company's operating revenue for the reporting period was ¥180,020,984.28, a decrease of 37.71% compared to ¥289,017,700.55 in the same period last year, primarily due to the impact of the pandemic on sales volume[55]. - The operating cost decreased by 34.45% to ¥133,246,292.26 from ¥203,273,341.42, also attributed to reduced sales volume due to the pandemic[55]. - The gross profit margin for pesticide intermediates and dimethomorph raw materials was 25.98%, down by 3.64% year-on-year[57]. - Research and development investment decreased by 22.62% to ¥12,058,494.59 from ¥15,582,615.62, reflecting the impact of the pandemic[57]. - The company reported a net profit loss of 7.94 million CNY from its subsidiary Jiangsu Yong'an during the reporting period due to the impact of the COVID-19 pandemic[87]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,193,761,351.10, a slight decrease of 0.42% from ¥1,198,791,073.40 at the end of the previous year[21]. - The company's current assets totaled CNY 752,868,935.38, down from CNY 796,245,029.33 at the end of 2019, indicating a decrease of approximately 5.5%[159]. - Cash and cash equivalents decreased significantly from CNY 485,277,103.96 at the end of 2019 to CNY 297,256,228.47, representing a decline of about 38.7%[158]. - Short-term borrowings increased from CNY 42,046,840.20 at the end of 2019 to CNY 90,101,803.54, reflecting an increase of approximately 114.5%[160]. - The total liabilities decreased from CNY 189,421,031.60 at the end of 2019 to CNY 181,808,100.72, a reduction of about 4.3%[160]. - The company's non-current assets increased from CNY 402,546,044.07 at the end of 2019 to CNY 440,892,415.72, marking an increase of approximately 9.5%[159]. - The total equity attributable to shareholders of the parent company increased to CNY 1,001,344,237.10 from CNY 998,434,546.01 at the end of 2019[164]. Research and Development - Research and development investment reached 12.06 million yuan, accounting for 6.7% of total revenue, with a total of 50 authorized patents, including 10 invention patents and 40 utility model patents[49]. - The company’s research and development focus is on environmentally friendly, efficient, and low-toxicity pesticides, aligning with national industrial policies[32]. - The company has developed a low-cost synthesis process for the insecticide Methomyl using by-products from the production of Dichloropropene[28]. - The company has successfully optimized production processes, leading to a significant reduction in by-product generation and overall production costs[40]. - The company plans to continue investing in R&D to enhance its core competitiveness and develop new products[89]. Production Capacity and Operations - The company has a production capacity of 8,000 tons of 4-nitro-ortho-xylene, 9,000 tons of N-(1-ethylpropyl)-3,4-dimethylbenzene, and 4,000 tons of 2,3-dimethylbenzene, positioning it among the leaders in the industry[33]. - The company’s subsidiary, Jiangsu Yong'an, has an annual production capacity of 12,000 tons of 95% dichloropropene and 4,000 kiloliters of 330 g/L emulsifiable concentrate[33]. - The company has developed a continuous production process for key intermediates and active ingredients, significantly improving production efficiency and reducing waste emissions[44]. - The company has become a leading global supplier of dimethenamid-P, achieving a full industry chain operation during the reporting period[89]. Market and Customer Relations - The company has established stable long-term relationships with numerous domestic and international clients, enhancing its market influence and competitive advantage[42]. - The company's top five customers accounted for 59.02% of total sales revenue, indicating a high customer concentration risk[90]. - The company’s overseas sales accounted for 59.15% of its main revenue, exposing it to foreign exchange fluctuation risks[96]. - The COVID-19 pandemic has posed challenges to market growth, prompting the company to optimize its product offerings and enhance customer satisfaction[88]. Environmental and Safety Compliance - The company has implemented a comprehensive wastewater treatment system to ensure legal and compliant discharge[127]. - The company has introduced advanced foreign waste gas treatment devices to enhance its waste gas management capabilities[127]. - The company reported no significant environmental violations, with all pollutant emissions within regulatory limits[125][126]. - The company has established a standardized hazardous waste temporary storage facility to manage solid waste properly[127]. - The company has established emergency response plans for environmental incidents, with documentation filed with local environmental authorities[130]. Corporate Governance and Shareholder Information - The financial report was approved by the board on August 27, 2020, indicating ongoing corporate governance practices[200]. - The total number of ordinary shareholders at the end of the reporting period was 12,752[140]. - Major shareholders include Ningbo Beisimei Investment holding 27.23% and Jiaxing Baohang Equity Investment holding 10.18%[140]. - The company did not undergo any changes in its controlling shareholder or actual controller during the reporting period[142]. - There were no significant litigation or arbitration matters during the reporting period[106].

证券代码：300796 证券简称： 贝斯美 公告编号：2020-031 绍兴贝斯美化工股份有限公司 关于参加浙江辖区上市公司投资者网上集体接待日活动的公告 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 为进一步加强与投资者特别是中小投资者的沟通交流，使广大投资者能更深入全 面了解绍兴贝斯美化工股份有限公司（以下简称"公司"）的经营情况，公司将参加 由浙江证监局指导、浙江上市公司协会与深圳市全景网络有限公司（以下简称"全景 网"） 共同举办的"凝心聚力 共克时艰"2020年浙江辖区上市公司投资者网上集体 接待日主题活动，现将有关事项公告如下： 本次投资者网上集体接待日活动将通过全景网提供的网上平台举行，投资者可以 登录"全景·路演天下"网站（http://rs.p5w.net）参与公司本次投资者网上接待日 活动。网上互动交流时间为2020年5月15日（星期五）下午15:00-17:00。届时公司董 事长陈峰先生、董事会秘书李晓博先生、财务总监屠汶君女士及相关工作人员将与投 资者通过网络在线交流形式就公司未来发展战略、经营 ...

Financial Performance - Total revenue for Q1 2020 was ¥68,161,117.78, a decrease of 53.00% compared to ¥145,024,586.11 in the same period last year[9] - Net profit attributable to shareholders was ¥865,485.13, down 96.15% from ¥22,462,366.68 year-on-year[9] - The net profit after deducting non-recurring gains and losses was -¥1,644,022.55, a decline of 107.31% compared to ¥22,503,985.13 in the previous year[9] - Basic earnings per share decreased by 96.00% to ¥0.01 from ¥0.25 year-on-year[9] - Operating income fell by 53.00% to ¥68,161,117.78, primarily impacted by the COVID-19 pandemic[16] - Net profit for Q1 2020 was ¥585,676.81, a decline of 97.5% compared to ¥23,556,376.66 in Q1 2019[46] - The company reported a total profit of ¥876,519.78 for Q1 2020, a decrease of 96.7% from ¥26,392,990.56 in the same period last year[46] Cash Flow - The net cash flow from operating activities was -¥19,383,367.31, an improvement of 49.74% from -¥38,566,561.30 in the same period last year[9] - Cash inflow from operating activities was CNY 126,516,023.20, up from CNY 98,576,998.07 in the previous period, representing an increase of approximately 28.4%[53] - Cash outflow from operating activities totaled CNY 145,899,390.51, compared to CNY 137,143,559.37 in the previous period, resulting in a net cash flow from operating activities of CNY -19,383,367.31, an improvement from CNY -38,566,561.30[54] - Cash flow from investing activities resulted in a net outflow of CNY -48,531,595.30, compared to CNY -15,319,382.51 in the previous period, indicating increased investment activity[54] - Cash flow from financing activities generated a net inflow of CNY 43,370,651.18, compared to CNY 34,474,770.94 in the previous period, reflecting a growth of approximately 26.5%[55] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,186,133,410.02, a decrease of 1.06% from ¥1,198,791,073.40 at the end of the previous year[9] - Total liabilities as of March 31, 2020, were CNY 176,367,817.93, down from CNY 189,421,031.60, a decrease of about 6.9%[38] - Total liabilities increased to ¥118,022,457.88 from ¥81,037,492.84, reflecting a growth of 45.6%[45] - The company's equity totaled CNY 1,009,765,592.09, slightly up from CNY 1,009,370,041.80, indicating a marginal increase of approximately 0.04%[39] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,337[12] - The largest shareholder, Ningbo Beisimei Investment Holding Co., Ltd., held 27.23% of the shares, amounting to 32,983,722 shares[12] Operational Insights - Accounts receivable decreased by 57.82% to ¥47,459,354.03 due to lower sales revenue[16] - Research and development expenses decreased by 50.96% to ¥4,205,790.78 due to delays in resuming work during the pandemic[16] - The total procurement amount from the top five suppliers decreased by 74.66% to ¥13,180,117.43, accounting for 52.32% of total procurement[18] - Sales revenue from the top five customers decreased by 50.22% to ¥46,920,496.32, representing 68.84% of total revenue[18] - The company plans to enhance its core competitiveness and minimize the impact of the pandemic on operations[18] Risk Management - The company faces risks related to high customer concentration, with the top five customers accounting for 68.84% of sales revenue[21] - The company aims to diversify its customer base to reduce reliance on major clients and mitigate potential operational risks[21] - The company has established a comprehensive safety production system and regularly conducts emergency drills to mitigate safety risks associated with hazardous chemicals[22] Environmental and Compliance - The company emphasizes environmental protection, investing in waste treatment systems to ensure compliance with national and local standards[24] - The company is classified as a national high-tech enterprise, benefiting from a 15% corporate income tax rate, but risks losing this status if it fails to renew its qualification[24] - The company has not reported any violations regarding the use and management of raised funds, ensuring compliance with regulations[30] Fundraising and Investment - The total amount of raised funds is CNY 39,297.76 million, with CNY 4,263.13 million invested in the current quarter, representing 16.21% of the total commitment[28] - The company has not changed the purpose of raised funds, maintaining a 0% change in usage ratio[28] - The company has committed to increasing production capacity and enhancing efficiency to offset potential impacts from changes in tax incentives[25] Miscellaneous - The company has successfully developed new pesticide products and obtained registration for the methomyl raw material[20] - There are no significant changes in project feasibility or non-operating fund occupation by controlling shareholders during the reporting period[32] - The company’s basic earnings per share and diluted earnings per share figures were not disclosed in the provided documents[51] - The company did not undergo an audit for the first quarter report[60]

Financial Performance - The company reported a profit distribution plan based on a total of 121,150,000 shares, proposing a cash dividend of 0.8 CNY per 10 shares (including tax) and no bonus shares[5]. - The company has a commitment to ensuring the accuracy and completeness of its financial reports, as stated by its management team[4]. - The company’s financial performance and strategic outlook are detailed in the annual report, highlighting key metrics and future plans[13]. - The company’s operating revenue for 2019 was ¥494,091,971.03, representing a 6.21% increase compared to ¥465,221,707.76 in 2018[18]. - The net profit attributable to shareholders decreased by 18.34% to ¥63,652,795.42 from ¥77,952,037.03 in the previous year[18]. - The net profit after deducting non-recurring gains and losses was ¥52,648,463.58, down 29.89% from ¥75,095,493.20 in 2018[18]. - The net cash flow from operating activities was ¥45,176,798.08, a decrease of 20.38% compared to ¥56,739,541.64 in 2018[18]. - The total assets at the end of 2019 reached ¥1,198,791,073.40, an increase of 77.31% from ¥676,093,189.69 in 2018[18]. - The net assets attributable to shareholders increased by 84.28% to ¥998,434,546.01 from ¥541,804,150.59 in 2018[18]. - The company achieved a total operating revenue of 494.09 million yuan in 2019, representing a year-on-year growth of 6.21%[65]. - The cash dividend amount for 2019 is 100% of the total profit distribution amount, indicating a full payout of available profits[123]. Market Strategy and Expansion - The company is focused on expanding its market presence and enhancing its product offerings, particularly in the agricultural chemicals sector[5]. - The company is actively expanding into new international markets, including Australia and other countries in Asia, while maintaining stable supply relationships with overseas customers[35]. - The company’s sales model includes direct sales for intermediates and active ingredients, while utilizing distributors for end-user products, reflecting a flexible approach to market demands[34]. - The company is focused on the research, production, and sales of environmentally friendly pesticide intermediates and formulations, with a core product layout of "1+3" centered around dimethenamid[28]. - The company has expanded the application range of dimethenamid to various crops, significantly increasing its market presence in developed regions[29]. - The company aims to enhance its product system by focusing on environmentally friendly pesticides, targeting leading positions in market share and production scale in specific segments[109]. Research and Development - The company has engaged a reputable accounting firm to ensure compliance and accuracy in its financial reporting[17]. - Research and development expenses amounted to 29.48 million yuan, accounting for 5.97% of total operating revenue, with 14 patents granted during the reporting period[61]. - The company holds 44 authorized patents, including 10 invention patents, and has established a provincial-level high-tech enterprise R&D center[49]. - The company is currently developing new products, including methoxyfenozide and benzoylpropionic acid, to lay a solid foundation for future growth[50]. - The company has successfully developed the synthesis processes for three new pesticide products, including methoxyfenozide and flufenoxuron, and aims for industrial production and market launch[114]. Environmental and Safety Compliance - The company continues to invest in safety and environmental protection, enhancing its operational processes and reducing waste emissions[62]. - The company has established a comprehensive safety production system to mitigate risks associated with hazardous chemicals used in its operations[117]. - Environmental protection measures are in place to manage waste and emissions, ensuring compliance with national and local standards[118]. - The company has established a comprehensive wastewater treatment system, ensuring effective collection and treatment of various wastewater types[167]. - The company has implemented advanced foreign waste gas treatment devices, enhancing its waste gas management capabilities[167]. Shareholder and Governance - The company has maintained a consistent approach to profit distribution, ensuring that minority shareholders' rights are protected[123]. - The company reported a lock-up period of 36 months for shares held by directors and senior management after the IPO, with a reduction limit of 25% per year during their tenure[129]. - The company emphasizes the importance of adhering to the regulations set by the China Securities Regulatory Commission and the Shenzhen Stock Exchange[130]. - The company has established a clear policy to avoid conflicts of interest and protect the rights of minority shareholders[135]. - The company has committed to transparency in related party transactions, adhering to legal and regulatory requirements[135]. Financial Management and IPO - The company completed its initial public offering (IPO) of 30.3 million shares at a price of 14.25 RMB per share, increasing total shares from 90,850,000 to 121,150,000[183]. - The company raised a total of RMB 431,775,000.00 through its initial public offering, with a net amount of RMB 392,977,600.00 after deducting issuance costs of RMB 38,797,400.00[90]. - The company plans to utilize the raised funds for future expansion and development initiatives[184]. - The company’s total share capital increased by 33.4% following the IPO[184]. - The company has established a clear strategy for managing share reductions in accordance with market conditions and legal requirements[130]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, indicating potential operational risks[5]. - The company maintains a procurement strategy to mitigate the impact of raw material price fluctuations on production costs[30]. - The company has formed stable and long-term cooperative relationships with numerous domestic and international clients, enhancing its market influence[52]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[165]. - The company has developed emergency response plans for environmental incidents, which have been filed with local environmental authorities[169].